The 33-year-old woman said: "I know this disease can take people quickly. I am so grateful for every day he is here." ...
The Japanese drugmaker will gain global rights to Aqneursa, a drug approved in the U.S. and E.U. for two inherited neurological disorders ...
PRESS RELEASE AB SCIENCE REPORTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2026 AND KEY EVENTS OF THE PERIODChange in AB Science's ...
Biotechs developing therapeutics to treat rare diseases include two that received FDA approvals this year for drugs to treat ...
Pharmaceutical Technology on MSN
Shionogi bolsters rare disease portfolio with $2BN IntraBio buyout
Shionogi's acquisition of IntraBio would expand its rare disease portfolio following the recent acquisition of ALS drug, ...
Former NASCAR driver Darrell Waltrip recently announced a diagnosis of frontotemporal dementia (FTD). Waltrip, a 3-time ...
Anthropic recently disclosed five cases in which users hid their countries while asking Claude for help enhancing pathogens ...
A new review charts how stem cell-derived human microglia, brain organoids and chimeric mice are overcoming the genetic and ...
Amyotrophic lateral sclerosis has always been a disease of contradictions. Two patients of the same age, diagnosed on the same day, with symptoms that began in the same part of the body, can follow ...
Scientists watched AIDS-related dementia symptoms resolve with antiretroviral treatment. This led to drug development ...
For decades, the complexity of the brain, limited understanding of disease biology and the formidable blood-brain barrier ...
Researchers developed a nanopore sequencing pipeline that may improve genetic diagnosis of repeat expansion disorders, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results